Wenjun Cheng

4PUBLICATIONS
5CO-AUTHORS
Solid tumoursMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 18, 2026
Tumour-derived SAA1 reprogrammes macrophages to promote CXCL1-mediated metastasis in Ovarian Cancer.

|Apr 15, 2026
Multiomics profiling and experiments in preclinical models revealed RAD51-IN-1 as a synergistic potentiator of anlotinib sensitivity.

|Dec 08, 2025
IL7R remodels immunosuppression tumor microenvironment and promotes macrophage polarization by regulating NF-κB/CXCL1 axis in ovarian cancer.

Yeqing Zheng, Cheng Qian, Shuyi Zhang

|Feb 19, 2024
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism.

Huixian Miao, Huangyang Meng, Yashuang Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Wenjun Cheng

2 joint publications

Huangyang Meng

1 joint publications

Huixian Miao

1 joint publications

Tian Chen